William De Nardo 3rd Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity 2022

Abstracts this author is presenting:

• Proteomic evaluation of hepatokine secretion in humans identifies EMILIN-1 as an inhibitor of fibrosis in non-alcoholic fatty liver disease — Poster Session 1